LENZ Therapeutics, Inc. (LENZ)
NASDAQ: LENZ · Real-Time Price · USD
28.96
-0.41 (-1.40%)
May 13, 2025, 4:00 PM - Market closed

LENZ Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Equivalents
23.0420.1635.1444.4418.31
Short-Term Investments
170.93188.8730.65--
Cash & Short-Term Investments
193.98209.0365.7944.4418.31
Cash Growth
-9.05%217.70%48.05%142.75%-
Prepaid Expenses
3.772.771.452.20.02
Restricted Cash
0.110.11---
Total Current Assets
197.86211.9267.2446.6418.32
Property, Plant & Equipment
21.990.370.280.01
Long-Term Deferred Charges
--2.74--
Other Long-Term Assets
1.41.40.020.030
Total Assets
201.25215.370.3846.9518.34
Accounts Payable
3.664.265.714.760.46
Accrued Expenses
4.45.5812.674.290.79
Current Portion of Leases
0.510.570.140.1-
Current Income Taxes Payable
---0.35-
Total Current Liabilities
8.5710.4118.519.51.25
Long-Term Leases
0.670.810.190.15-
Other Long-Term Liabilities
--0.120.07-
Total Liabilities
9.2411.2218.839.711.25
Common Stock
005.915.915.9
Additional Paid-In Capital
351.52348.92.521.10.25
Retained Earnings
-159.63-145.01-95.25-25.28-14.47
Comprehensive Income & Other
0.120.20.01--
Total Common Equity
192.01204.08-86.81-18.27-8.31
Shareholders' Equity
192.01204.0851.5537.2417.08
Total Liabilities & Equity
201.25215.370.3846.9518.34
Total Debt
1.181.380.330.25-
Net Cash (Debt)
192.79207.6565.4744.1918.31
Net Cash Growth
-9.35%217.19%48.14%141.39%-
Net Cash Per Share
7.149.7633.424.671.96
Filing Date Shares Outstanding
28.1527.5425.539.639.36
Total Common Shares Outstanding
27.5427.529.749.639.36
Working Capital
189.29201.5148.7337.1417.07
Book Value Per Share
6.977.42-8.91-1.90-0.89
Tangible Book Value
192.01204.08-86.81-18.27-8.31
Tangible Book Value Per Share
6.977.42-8.91-1.90-0.89
Machinery
-0.480.070.050.02
Leasehold Improvements
-0.10.01--
Updated Mar 19, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q